In vivo pharmacokinetics, biodistribution and antitumor effect of amphiphilic poly(L-amino acids) micelles loaded with a novel all-trans retinoic acid derivative.

[1]  Feihu Chen,et al.  Anti-tumor effect of 4-Amino-2-Trifluoromethyl-Phenyl Retinate on human breast cancer MCF-7 cells via up-regulation of retinoid receptor-induced gene-1. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Yuan Wang,et al.  A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Jianping Zhou,et al.  Synthesis, characterization, drug-loading capacity and safety of novel pH-independent amphiphilic amino acid copolymer micelles. , 2012, Die Pharmazie.

[4]  A. Schätzlein,et al.  Amphiphilic poly(L-amino acids) - new materials for drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Wu Fei,et al.  Effects of 4-amino-2-trifluoromethyl-phenyl Retinate on Differentiation of Human Digestive System Tumor Cells in vitro , 2011 .

[6]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[7]  Supriya Shidhaye,et al.  Advances in polymeric micelles for drug delivery and tumor targeting. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[8]  C. Allen,et al.  Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Kazunori Kataoka,et al.  Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. , 2009, Advanced drug delivery reviews.

[10]  R. Kuchta,et al.  Introduction to cancer chemotherapeutics. , 2009, Chemical reviews.

[11]  Y. Wang,et al.  Synthesis and anti-tumor activity of all-trans retinoic acid derivatives , 2009 .

[12]  D. S. Lee,et al.  Synthesis and characterization of poly(l-glutamic acid)-block-poly(l-phenylalanine) , 2009 .

[13]  Xuesi Chen,et al.  Direct formation of giant vesicles from synthetic polypeptides. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[14]  I. Theobald,et al.  Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life. , 2007, Protein engineering, design & selection : PEDS.

[15]  W. Hennink,et al.  Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes. , 2007, International journal of pharmaceutics.

[16]  Daniel T Kamei,et al.  Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery. , 2007, Nature materials.

[17]  T. Onda,et al.  Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. , 2006, Cancer research.

[18]  B. Xiao,et al.  Inhibition of growth and increase of alkaline phosphatase activity in cultured human oral cancer cells by all-trans retinoic acid. , 2006, International journal of oral and maxillofacial surgery.

[19]  N. Nishiyama,et al.  Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats , 2005, British Journal of Cancer.

[20]  K. Kataoka,et al.  NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel , 2005, British Journal of Cancer.

[21]  Marek Langner,et al.  Repeated injections of PEG-PE liposomes generate anti-PEG antibodies. , 2005, Cellular & molecular biology letters.

[22]  G. Bartolini,et al.  Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29. , 2004, Anticancer research.

[23]  A. Montag,et al.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  A. Ristimäki,et al.  Cyclooxygenase‐2 expression during carcinogenesis in the human stomach , 2002, The Journal of pathology.

[25]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[26]  L. Brinton.  INTRODUCTION TO CANCER , 2000 .

[27]  P. Couvreur,et al.  Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting , 1999 .

[28]  Y. Imanishi,et al.  Amphiphilic poly(Ala)-b-poly(Sar) microspheres loaded with hydrophobic drug. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[29]  F. Sinigaglia,et al.  Motifs and supermotifs for MHC class II binding peptides , 1995, The Journal of experimental medicine.

[30]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[31]  T. Okano,et al.  Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.

[32]  F. Zunino,et al.  Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug. , 1985, British Journal of Cancer.